ZLN005, also known as 2-(4-tert-Butylphenyl) benzimidazole, is a PGC-1α transcriptional regulator shows antidiabetic efficacy in a mouse model. ZLN005是新型过氧化物增殖激活受体协同激活子(PGC-1α)转录调节剂。
ZLN005 increases expression of the PGC-1α gene in L6 myotubes. ZLN005 increased PGC-1α mRNA levels in a dose-dependent manner; 20 μmol/L ZLN005 caused a threefold increase over the control after 24 h. At 10 μmol/L, the PGC-1α mRNA levels were increased to almost the same extent at 16 to 48 h. ZLN005 did not increase the expression of the PGC-1α gene in rat primary hepatocytes.
Cardiomyocytesisolation and culture[1]
Neonatal mouse cardiomyocytes were isolatedaccording to a previously described method, with little modification. In brief,hearts of neonatal mice were removed surgically, and the ventricles were enzymaticallydigested in 0.1% collagenase II for 25 min in a thermostat at 37OC.After collection, centrifugation, and resuspension, cells were pre-plated for 2hin DMEM supplemented with 15% FBS to reduce non-myocyte contamination and thenplated in culture dishes and incubated at 37OC in 5% CO2incubator. After 3–4 days, cells were incubated in a serum-free essentialmedium overnight before treatment with the indicated procedures. The cells werethen incubated in serum-containing medium, with a normal glucose concentration (5.5mMD-glucose) or HG concentration (33mM D-glucose) for 24h. ZLN005 treatment was appliedsimultaneously in specific groups (the concentration of ZLN005 was 4μM,unless noted otherwise).
Cellviability assay
Cell viability was measured by3-(4, 5-Dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT).For the MTT assay, cells were plated on 96-wellplates at the density of 3X105cells/ml (1ml/well) prior to treatment.After treatment, MTT solution was added, and the cells were incubated for an additional4h. Then, the solution was aspirated, and DMSO was added to dissolve theformazan crystals. The final solution was transferred to a 96-well plate, and theabsorbance was measured at 570nm using a microplate absorbance spectrophotometer.Theresults were expressed as a percentage of control.
Animal experiments[2]
Male C57BKS db/db and lean littermateC57BKS mice were housed in a temperature controlled room (22±2°C) with a 12-h light/dark cycle. For chronic treatment, six toeight 8-weekold mice were assigned randomly to the various treatment groups bybody weight and glucose levels. Lean and db/db mice received oraladministration of either vehicle (0.5% methylcellulose), ZLN005, or metforminfor 6 weeks. Body weight and food intake were recorded daily.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Li W, Li X, Wang B, et al. ZLN005 protects cardiomyocytes against high glucose-induced cytotoxicity by promoting SIRT1 expression and autophagy. Exp Cell Res. 2016;345(1):25-36.
[more]
分子式 C17H18N2 |
分子量 250.34 |
CAS号 49671-76-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 35 mg/mL |
Water <1 mg/mL |
Ethanol 3 mg/mL |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们